Literature DB >> 12361487

Update on the role of triglycerides as a risk factor for coronary heart disease.

Michael Miller1, Barbara Cosgrove, Stephen Havas.   

Abstract

Elevated triglyceride levels represent an independent risk factor for coronary heart disease, and recently the National Cholesterol Education Program revised the acceptable level of fasting triglycerides from less than 200 mg/dL to below 150 mg/dL. However, a sizeable proportion of people in Western societies has persistently elevated triglyceride levels. Fortunately, hygienic and pharmacologic measures can have a considerable impact on reducing triglyceride levels. However, an important yet unanswered question is whether decreasing triglycerides beyond low-density lipoprotein cholesterol lowering contributes significantly to additional coronary heart disease event reduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361487     DOI: 10.1007/s11883-002-0044-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  27 in total

1.  Regular physical activity and coronary risk factors in Japanese men.

Authors:  S D Hsieh; H Yoshinaga; T Muto; Y Sakurai
Journal:  Circulation       Date:  1998-02-24       Impact factor: 29.690

2.  Total fat intake modifies plasma fatty acid composition in humans.

Authors:  S K Raatz; D Bibus; W Thomas; P Kris-Etherton
Journal:  J Nutr       Date:  2001-02       Impact factor: 4.798

3.  High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations.

Authors:  P M Kris-Etherton; T A Pearson; Y Wan; R L Hargrove; K Moriarty; V Fishell; T D Etherton
Journal:  Am J Clin Nutr       Date:  1999-12       Impact factor: 7.045

4.  Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Authors:  H Iso; Y Naito; S Sato; A Kitamura; T Okamura; T Sankai; T Shimamoto; M Iida; Y Komachi
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

5.  Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

Authors:  Roberto Marchioli; Federica Barzi; Elena Bomba; Carmine Chieffo; Domenico Di Gregorio; Rocco Di Mascio; Maria Grazia Franzosi; Enrico Geraci; Giacomo Levantesi; Aldo Pietro Maggioni; Loredana Mantini; Rosa Maria Marfisi; G Mastrogiuseppe; Nicola Mininni; Gian Luigi Nicolosi; Massimo Santini; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Corrado Tucci; Franco Valagussa
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

6.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

Review 7.  n-3 polyunsaturated fatty acids and cardiovascular diseases.

Authors:  A Nordøy; R Marchioli; H Arnesen; J Videbaek
Journal:  Lipids       Date:  2001       Impact factor: 1.880

8.  Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study.

Authors: 
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

9.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

10.  Incorporation of oleic acid and eicosapentaenoic acid into glycerolipids of cultured normal human fibroblasts.

Authors:  M Miller; M Motevalli; D Westphal; P O Kwiterovich
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.